Michael Patterson, DO
Ophthalmology · Crossville, TNNPI 1851654867
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $101,884 of the $138,327 with a category attached, or 73.7%. 35 manufacturers reported payments, led by Bausch & Lomb Americas Inc. at 31.6% of the total. Among ophthalmology clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 416 payments — averaging $332.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bausch & Lomb Americas Inc.$44K
- Johnson & Johnson Surgical Vision, Inc.$39K
- Bausch & Lomb, A Division Of Bausch Health US, LLC$17K
- Ivantis, Inc$10K
- Sight Sciences, Inc.$8K
- Glaukos Corporation$6K
- plus $14K from 29 others
Across 2 payments — averaging $8500.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Carl Zeiss Meditec, Inc.$17K
What the payments were for
- Consulting fees$101,88474%
- Speaking & faculty fees$22,55016%
- Travel & lodging$3,2232%
- Food & beverage$10,6698%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bausch & Lomb Americas Inc. | 57 | $43,754 |
| Johnson & Johnson Surgical Vision, Inc. | 40 | $39,119 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 38 | $16,906 |
| Ivantis, Inc | 15 | $10,323 |
| Sight Sciences, Inc. | 10 | $8,318 |
| Glaukos Corporation | 22 | $5,915 |
| Carl Zeiss Meditec, Inc. | 7 | $4,146 |
| NEW World Medical,inc. | 16 | $3,289 |
| AbbVie(2 entities) | 84 | $2,923 |
| Alcon | 31 | $870 |
| Harrow Eye, LLC | 10 | $548 |
| Carl Zeiss Meditec USA, Inc. | 5 | $477 |
| Genentech USA, Inc. | 16 | $396 |
| Apellis Pharmaceuticals, Inc. | 12 | $289 |
| Regeneron Healthcare Solutions, Inc. | 11 | $207 |
| Omeros Corporation | 7 | $193 |
| Novartis | 6 | $84 |
| Staar Surgical Company | 1 | $82 |
| Mallinckrodt Hospital Products Inc. | 3 | $55 |
| Dompe US, Inc. | 2 | $51 |
| Sun Pharmaceutical Industries Inc. | 3 | $51 |
| Rayner Intraocular Lenses Limited | 2 | $45 |
| Biotissue Holdings Inc. | 3 | $45 |
| Alimera Sciences, Inc. | 2 | $38 |
| Eyevance Pharmaceuticals LLC | 2 | $34 |
| Iridex Corporation | 2 | $33 |
| Astellas Pharma US Inc | 1 | $25 |
| Biogen | 1 | $18 |
| Amgen | 1 | $16 |
| ANI Pharmaceuticals, Inc. | 1 | $15 |
| Oyster Point Pharma, Inc. | 1 | $15 |
| Lombart Brothers, Inc. | 1 | $13 |
| Rxsight Inc | 1 | $12 |
| Ocular Therapeutix, Inc. | 1 | $12 |
| Eyepoint US, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Compact Intuitiv$31,359
- IFS ADVANCED FEMTOSEC LASER$30,734
- INTRALASE FS FEMTOSEC LASER$30,734
- enVista MX60 IOL$13,457
- ENVISTA$10,400
- ENVISTA ENVY IOL$9,800
- TRULIGN TORIC$9,400
- CRYSTALENS$9,400
- STELLARIS$8,650
- OMNI$8,250
- STELLARIS ELITE$8,199
- Hydrus$7,364
- OPHTHALMIC INSTRUMENTS$6,400
- Crystalens Accommodating IOL (AT-52AO)$5,800
- IC-8 Apthera IOL$5,750
- iStent inject Trabecular Micro-Bypass Stent System$3,132
- CALLISTO eye$3,018
- Trulign IOL$3,000
- Tecnis Multifocal Family of 1-piece IOLS$2,918
- enVista Aspire IOL$2,800
How this compares
$138,327 in reported general payments places this provider in the 95th percentile of 323 ophthalmology providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 53 | $69,650 |
| XiidraLifitegrast | 11 | $18,491 |
| Cyclosporine | 19 | $13,670 |
| Prednisolone Acetate | 335 | $13,620 |
| Fluorometholone | 126 | $10,867 |
| LumiganBimatoprost | 12 | $9,728 |
| CombiganBrimonidine Tartrate/Timolol | 15 | $7,491 |
| Latanoprost | 558 | $7,013 |
| Alphagan PBrimonidine Tartrate | 12 | $4,060 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 172 | $3,170 |
| ErythromycinErythromycin Base | 240 | $2,524 |
| Brimonidine Tartrate | 49 | $1,631 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 135 | $1,534 |
| Timolol Maleate | 125 | $1,374 |
| Ketorolac Tromethamine | 66 | $1,203 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRestasis, Lumigan, Combigan, Alphagan P | $2,923 | $90,92992 claims |
| Bausch & Lomb Americas Inc.Xiidra | $43,754 | $18,49111 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 323 ophthalmology providers in Tennessee.
Other ophthalmology in Crossville
- Larry PattersonCrossville$57K
- Deborah ShermanNashville$3M
- Melissa ToyosMemphis$1.3M
- Rolando ToyosMemphis$809K
- Brian BiesmanNashville$630K
- Brian FowlerMemphis$206K
- Edward ChaumNashville$158K
- Brian JerkinsMemphis$150K
- James FreemanMemphis$141K
- John FreemanMemphis$136K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.